OMADA HEALTH INCOMDA
ASignal's systematic analysis rates OMDA as Neutral.
Reflects the latest available analysis · analyzed Sep 16, 2026
The case on OMDA
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (43.1% YoY)
- High gross margin (68.19%) indicating pricing power
- Zero total debt and strong liquidity (current ratio 3.91x)
- Positive free cash flow ($11.92M)
- High cash balance ($221.71M)
- RSI near oversold level (29.13), potential rebound
- Bearish MACD (MACD < signal line, negative histogram)
- Negative price momentum (-0.139)
- Low net profit margin (1.39%) and negative ROA (-0.09%)
- Very low return on equity (1.84%)
- High EV/EBITDA (180.89x) suggesting valuation concerns
- No Reddit mentions, limited retail sentiment data
See the full verdict on OMDA
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes OMDA
Most investors never get a second opinion, let alone several. ASignal runs OMDA past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.